Herbert L DuPont (H L DuPont)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 9

Top Venues

Microorganisms

Therapeutic advances in gastroenterology

Antibiotics (Basel, Switzerland)

Science translational medicine

University of Texas School of Public Health

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Texas School of Public Health

United States

Professor of Infectious Diseases :: Epidemiology

University of Texas Medical School at Houston Apr 01 1973

United States

Professor :: Internal Medicine

Publications

Herbert L DuPont, Andrew W DuPont, Glenn S Tillotson
Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone. Therapeutic advances in gastroenterology 17 (2024)
Herbert L DuPont, Andrew W DuPont, Glenn S Tillotson
Microbiota restoration therapies for recurrent Clostridioides difficile infection reach an important new milestone. Therapeutic advances in gastroenterology 17 (2024)
Herbert L DuPont, Madeleine Mary Hines Salge
The Importance of a Healthy Microbiome in Pregnancy and Infancy and Microbiota Treatment to Reverse Dysbiosis for Improved Health. Antibiotics (Basel, Switzerland) 12 (11) (2023)
Herbert L DuPont
The potential for development of clinically relevant microbial resistance to rifaximin-α: a narrative review. Clinical microbiology reviews (2023)
Taylor M Halsey, Anusha S Thomas, Tomo Hayase, Weijie Ma, Hamzah Abu-Sbeih, Baohua Sun, Edwin Roger Parra, Zhi-Dong Jiang, Herbert L DuPont, Christopher Sanchez, Rawan El-Himri, Alexandria Brown, Ivonne Flores, Lauren McDaniel, Miriam Ortega Turrubiates, Matthew Hensel, Dung Pham, Stephanie S Watowich, Eiko Hayase, Chia-Chi Chang, Robert R Jenq, Yinghong Wang
Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis. Science translational medicine 15 (700) (2023)
Herbert L DuPont, Zhi-Dong Jiang, Ashley S Alexander, Andrew W DuPont, Eric L Brown
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation. Microorganisms 11 (1) (2022)
Herbert L DuPont, Zhi-Dong Jiang, Ashley S Alexander, Andrew W DuPont, Eric L Brown
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation. Microorganisms 11 (1) (2022)
Herbert L DuPont, Zhi-Dong Jiang, Ashley S Alexander, Andrew W DuPont, Eric L Brown
Intestinal IgA-Coated Bacteria in Healthy- and Altered-Microbiomes (Dysbiosis) and Predictive Value in Successful Fecal Microbiota Transplantation. Microorganisms 11 (1) (2022)
Z D Jiang, N J Ajami, J F Petrosino, G Jun, C L Hanis, M Shah, L Hochman, V Ankoma-Sey, A W DuPont, M C Wong, A Alexander, S Ke, Herbert L DuPont
Randomised clinical trial: faecal microbiota transplantation for recurrent Clostridum difficile infection - fresh, or frozen, or lyophilised microbiota from a small pool of healthy donors delivered by colonoscopy. Alimentary pharmacology & therapeutics 45 (7) (2017)

Herbert L DuPont.css-eqlu8i{font-size:small;padding-left:4px;} (H L DuPont)

Publication Activity (10 Years)

Top Topics

Top Venues

Herbert L DuPont (H L DuPont)